Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB)

Historical Holders from Q1 2021 to Q3 2025

Symbol
CNTB on Nasdaq
Type / Class
Equity / Ordinary Shares, par value $0.000174
Shares outstanding
55,833,616
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,582
Holdings value
$2,389
Number of holders
1
Number of sells
-16
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Panacea Innovation Ltd 25.1% $13,950,000 13,950,000 Panacea Innovation Limited 21 Jul 2025
Wei Zheng 9.9% $8,347,120 5,527,528 Wei Zheng 26 Nov 2025

Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 (CNTB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1,582 $2,389 -$2,397,515 $1.51 1
2025 Q2 2,444,820 $2,399,065 -$179,460 $0.98 17
2025 Q1 2,827,742 $1,555,037 -$242,900 $0.55 13
2024 Q4 3,181,027 $4,372,490 +$306,229 $1.38 14
2024 Q3 2,944,726 $4,229,340 +$101,251 $1.44 11
2024 Q2 2,976,236 $4,523,173 -$1,478,482 $1.52 12
2024 Q1 3,947,159 $6,867,831 -$3,787,306 $1.74 11
2023 Q4 7,118,656 $8,400,371 -$3,060,514 $1.18 14
2023 Q3 10,078,543 $8,221,166 -$60,098 $0.7969 12
2023 Q2 10,358,458 $11,684,999 -$631,607 $1.11 15
2023 Q1 10,919,115 $10,918,005 -$44,044 $0.9999 15
2022 Q4 11,067,830 $9,603,876 +$2,501 $0.8678 18
2022 Q3 217,709 $282,000 -$1,721,326 $1.67 5
2022 Q2 14,969,473 $13,034,000 -$10,410,998 $0.8703 26
2022 Q1 17,687,819 $53,391,000 -$622,344 $3.02 26
2021 Q4 16,966,777 $87,370,000 -$80,695,326 $5.15 28
2021 Q3 19,395,645 $467,497,000 +$8,028,087 $24.2 20
2021 Q2 19,072,268 $372,436,000 +$73,098,989 $19.53 16
2021 Q1 15,391,128 $284,643,000 +$284,643,000 $18.5 26